The Australian Prostate Cancer Research Centre –New South Wales (APCRC-NSW) is a newly established and funded centre and is part of the national APCRC initiative that includes centres within Victoria and Queensland. The APCRC-NSW is a comprehensive, multidisciplinary and multi-institutional research team brought together over more than 20 years through a common interest in the bidirectional flow of prostate cancer research between basic science and clinical practice.
The multi-institutional NSW centre brings together both clinical and basic prostate cancer researchers from St Vincent’s Clinic and Hospital, St Vincent’s Prostate Cancer Centre, The Kinghorn Cancer Centre, The Garvan Institute of Medical Research, Royal Prince Alfred, Concord and Royal North Shore Hospitals and the Chris O’Brien Lifehouse.
The team has expertise that covers the breadth of contemporary prostate cancer research. Broadly, research areas of interest include urological oncology, targeted biomarker and therapeutic target discovery, pathology and medical oncology, radiation oncology, radiology, epigenetics and the genetic origins of the disease.
The members of the APCRC-NSW team are:
|Prof Phillip Stricker (Chair)||Urologist, St Vincent's Prostate Cancer Centre|
|Prof Susan Clark||Scientist, The Garvan Institute of Medical Research/ The Kinghorn Cancer Centre|
|Prof Vanessa Hayes||Scientist, The Garvan Institute of Medical Research/ The Kinghorn Cancer Centre/ University of Sydney Medical School|
|A/Prof Lisa Horvath||Medical Oncologist, Royal Prince Alfred Hospital/ Chris O'Brien Lifehouse/ The Garvan Institute of Medical Research/ The Kinghorn Cancer Centre|
|Prof James Kench||Pathologist, Royal Prince Alfred Hospital/ The Garvan Institute of Medical Research/ The Kinghorn Cancer Centre|
|Dr Kris Rasiah||Urologist, Royal North Shore Hospital/ The Garvan Institute of Medical Research/ The Kinghorn Cancer Centre|
Central to the APCRC-NSW’s research is its biobank and clinical information database, Cansto. It has been in operation for over twenty years and houses follow up clinical information and tissue specimens of over 13,000 men with prostate cancer. This ongoing resource has allowed local, national and international researchers, through collaborative ventures, to examine many aspects of prostate cancer, including its aetiology, biology and outcomes of treatments. It is also a rare and valuable resource as only a few institutions have the calibre to collect tissues samples to an international standard and marry it with clinical data that follow patients from the time of diagnosis, treatment and then ultimately to death.
The APCRC-NSW is funded through a grant from the Commonwealth Department of Health and Ageing.